Cloud-Connected Automated Intravenous (IV) Compounding Market Report 2026

Cloud-Connected Automated Intravenous (IV) Compounding Market Overview

• Cloud-Connected Automated Intravenous (IV) Compounding market size has reached to $2.34 billion in 2025 • Expected to grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 16.5% • Growth Driver: Enhancing Biosimilar Safety And Accuracy Drives The Market Reducing Errors And Ensuring Precision • Market Trend: Advancing Cloud-Connected Automated IV Compounding With Real-Time Monitoring And Regulatory Compliance • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cloud-Connected Automated Intravenous (IV) Compounding Market?

Cloud-connected automated intravenous (IV) compounding is a technology-driven approach that uses robotics and digital systems to prepare intravenous medications with high precision. It integrates cloud connectivity to enable real-time oversight, data management, and continuous performance optimization. It enhances safety, accuracy, and efficiency by combining automation with intelligent remote capabilities. The main product types of cloud-connected automated IV compounding are including robotic compounding systems, software solutions, and consumables. Robotic compounding systems refer to automated machines integrated with cloud connectivity that prepare intravenous medications with high precision and accuracy, while enabling remote monitoring, data management, and workflow optimization. These systems can be deployed through cloud-hosted, hybrid cloud, or on-premise with cloud integration models. The applications hospital pharmacies, oncology centers, homecare settings, and others and the key end users such as hospitals, clinics, ambulatory surgical centers, and others.

What Is The Cloud-Connected Automated Intravenous (IV) Compounding Market Growth Forecast?

The cloud-connected automated intravenous (IV) compounding market size is expected to see rapid growth in the next few years. It will grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to increasing integration of cloud-based monitoring solutions, growing development of AI-powered error detection systems, rising investment in compact and modular robotic designs, expansion of homecare and decentralized pharmacy applications, and growing focus on interoperability and data analytics platforms. Major trends in the forecast period include technology advancement in cloud-connected workflow management, innovation in AI and machine learning for predictive compounding, development of smart consumables and sensors, research and development in oncology-specific automation solutions, and investment in scalable and remote monitoring deployment models.

Global Cloud-Connected Automated Intravenous (IV) Compounding Market Segmentation

1) By Product Type: Robotic Compounding Systems, Software Solutions, Consumables 2) By Deployment Mode: Cloud-Hosted Deployment, Hybrid Cloud Deployment, On-Premise With Cloud Integration 3) By Application: Hospital Pharmacies, Oncology Centers, Homecare Settings, Other Applications 4) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Robotic Compounding Systems: Automated Intravenous Preparation Robots, Modular Robotic Compounding Units, Sterile Compounding Robotic Arms, Integrated Safety Monitoring Systems 2) By Software Solutions: Workflow Management Software, Inventory Management Software, Dose Verification Software, Remote Monitoring And Analytics Software 3) By Consumables: Sterile Syringes, Intravenous Bags, Vials And Ampoules, Filters And Tubing Sets, Protective Personal Equipment

What Is The Driver Of The Cloud-Connected Automated Intravenous (IV) Compounding Market?

The rising demand for biosimilars is expected to propel the growth of the cloud-connected automated IV compounding market going forward. Biosimilars are biologic medical products highly similar to an already approved reference biologic, with no clinically meaningful differences in safety, purity, or efficacy. Rising demand for biosimilars is due to their cost-effectiveness compared to branded biologics. Automated IV compounding enhances the safe and accurate preparation of biosimilars by reducing human error, ensuring precise dosing, and maintaining product integrity. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, as of January 2022, the U.S. had 33 FDA-approved biosimilar products, with 21 available on the market and by 2023, this number increased to 40 FDA-approved biosimilars, with 25 of them commercially available. Therefore, the increasing demand for biosimilars drives the cloud-connected automated IV compounding market.

Key Players In The Global Cloud-Connected Automated Intravenous (IV) Compounding Market

Major companies operating in the cloud-connected automated intravenous (iv) compounding market are McKesson Corporation, Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen SE, Fresenius Kabi AG, Grifols S.A., ICU Medical Inc., Syntegon Technology GmbH, Omnicell Inc., Marchesini Group S.p.A., Swisslog Healthcare, ScriptPro LLC, Parata Systems LLC, ARxIUM Inc., Equashield LLC, Health Robotics S.r.l., Rommelag AG, NewIcon Oy, DoseEdge, Aesynt Inc.

Global Cloud-Connected Automated Intravenous (IV) Compounding Market Trends and Insights

Major companies operating in the cloud-connected automated intravenous (IV) compounding market are focusing on enhancing automated systems, such as cloud-enabled monitoring and compliance tracking, to improve sterile preparation accuracy, reduce medication errors, and strengthen regulatory adherence. Cloud-enabled monitoring and compliance tracking refers to integrated software and hardware features that allow healthcare facilities to access real-time data on IV compounding processes, maintain electronic audit trails, and ensure adherence to sterility and quality standards across multiple sites. For instance, in May 2025, the United States Food and Drug Administration (FDA), a US-based regulatory authority, emphasized updated guidance and enforcement initiatives under section 503B of the Federal Food, Drug, and Cosmetic Act, which require outsourcing facilities to maintain rigorous quality control and documentation for compounded sterile products. These guidelines encourage the adoption of automated IV compounding systems with cloud-based monitoring, electronic record-keeping, and remote quality oversight capabilities.

What Are Latest Mergers And Acquisitions In The Cloud-Connected Automated Intravenous (IV) Compounding Market?

In October 2025, Omnicell Inc., a US-based provider of healthcare automation and medication management systems, acquired ANiGENT LLC for an undisclosed amount. Through this acquisition, Omnicell aims to expand its cloud-enabled medication management platform by integrating advanced drug diversion detection and intelligence capabilities, thereby strengthening its connected automation offerings, including cloud-connected IV compounding workflows. ANiGENT LLC is a US-based company specializing in cloud-connected automated intravenous (IV) compounding solutions.

Regional Insights

North America was the largest region in the cloud-connected automated intravenous (IV) compounding market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cloud-Connected Automated Intravenous (IV) Compounding Market?

The cloud-connected automated intravenous (IV) compounding market includes revenues earned by entities by providing services such as remote monitoring and support, workflow optimization services, cloud data management, system integration services, and predictive maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloud-connected automated IV compounding market consists of sales of automated IV compounding robots, cloud-connected workstations, sterile compounding isolators, IV workflow software platforms, and medication preparation sensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cloud-Connected Automated Intravenous (IV) Compounding Market Report 2026?

The cloud-connected automated intravenous (iv) compounding market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cloud-connected automated intravenous (iv) compounding industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.